Leukocyte adhesion deficiency-1: Difference between revisions
CSV import |
CSV import Tag: Reverted |
||
| Line 65: | Line 65: | ||
{{Cell surface receptor deficiencies}} | {{Cell surface receptor deficiencies}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | |||
Revision as of 22:34, 10 February 2025
Leukocyte adhesion deficiency-1 (LAD1) is a rare and often fatal genetic disorder in humans.
Signs
The main sign of the disease is life-threatening, recurrent bacterial or fungal soft tissue infections. These infections are often apparent at birth and may spread throughout the body. Omphalitis (infection of the umbilical cord stump) is common shortly after birth. Other signs include delayed separation of the umbilical cord, periodontal disease, elevated neutrophils, and impaired wound healing, but not increased vulnerability to viral infections or cancer. Such patients have fever as the manifestation of infection, inflammatory responses are indolent.
Mechanism
LAD1 is caused by mutations in the ITGB2 gene which are inherited autorecessively. This gene encodes CD18, a protein present in several cell surface receptor complexes found on white blood cells,<ref name="Etzioni">Etzioni A, Harlan JM. Cell adhesion and leukocyte adhesion defects. In: Ochs HD, Smith CIE, Puck JM, eds. Primary immunodeficiency diseases: a molecular and genetic approach. Oxford: Oxford University Press, 2007:550–564.</ref> including lymphocyte function-associated antigen 1 (LFA-1), complement receptor 3 (CR-3), and complement receptor 4 (CR-4). The deficiency of LFA-1 causes neutrophils to be unable to adhere to and migrate out of blood vessels, so their counts can be high. It also impairs immune cell interaction, immune recognition, and cell-killing lymphocyte functions. The lack of CR3 interferes with chemotaxis, phagocytosis, and respiratory burst
Diagnosis
Flow cytometry with monoclonal antibodies is used to screen for deficiencies of CD18.
Treatment
Because the CD18 gene has been cloned and sequenced, this disorder is a potential candidate for gene therapy.<ref>Candotti F, Fischer A. Gene therapy. In: Ochs HD, Smith CIE, Puck JM, eds. Primary immunodeficiency diseases: a molecular and genetic approach. Oxford: Oxford University Press, 2007:688–705.</ref>
Epidemiology
As of 2010[update], LAD1 has been observed in several hundred children worldwide.<ref>,
Defects in the leukocyte adhesion cascade, Clinic Rev Allerg Immunol, 2010, Vol. 38(Issue: 1), pp. 54–60, DOI: 10.1007/s12016-009-8132-3, PMID: 19437145,</ref>
See also
References
<references group="" responsive="1"></references>
External links
| Hematologic disease: Monocyte and granulocyte disease (CFU-GM/CFU-Baso/CFU-Eos), including immunodeficiency (D70-D71, 288) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- Articles containing potentially dated statements from 2010
- Articles with invalid date parameter in template
- All articles containing potentially dated statements
- Autosomal recessive disorders
- Congenital defects of phagocyte number, function, or both
- Rare diseases
- Medicine
- Medical dictionary
- Pages with no images
